Pfizer Stock News

Paxlovid, Pfizer''s oral treatment for COVID-19, became available to eligible patients in Alberta for the first time on Monday. The province has an initial stockpile of 3,200 sets of pills.

Paxlovid, Pfizer''s oral treatment for COVID-19, became available to eligible patients in Alberta for the first time on Monday. The province has an initial stockpile of 3,200 sets of pills.

Pfizer has asked the U.S. to authorize a two-dose regimen for children ages 6 months to 5 years old.

Pfizer asks FDA to allow low-dose COVID-19 shots for children under 5, a big step toward vaccinating America''s youngest

Pfizer (PFE) announced the appointment of Dr. William Pao as the companys Executive Vice President and Chief Development Officer effective March 22

In a global first, Pfizer is to ask US vaccines regulator to authorise two doses for the age group.

After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned. About 3 new molecular entities, or NMEs, were approved during the month, including Immunocore Holdings plc''s (NASDAQ: IMCR ) Kimmtrak for certain patients with advanced eye melanoma and Pfizer, Inc.''s (NYSE: PFE ) atopic dermatitis treatment Cibinqo. NME approval is an important indicator to measure innovation in drug research. NME approvals totaled 50 in 2021, almost equaling the numbers of the previous year. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN )- Sanofi (NASDAQ: SNY ), however, failed to get the nod for expanding the Libtayo label to include cervical cancer. Pfizer also faced rejection for its pediatric growth hormone deficiency treatment Somatrogon. A PDUFA date is the date/period by which the Food and Drug Administration is required to announce its verdict on a sponsor company''s regulatory application. This will determine the fate of millions of dollars invested in developing the treatment from the preclinical-stage to clinical testing.

Watch: CBS News Tells Viewers Joe Rogan Is Killing People Authored by Steve Watson via Summit News, CBS News addressed the ongoing targeting of Joe Rogan for censorship, suggesting that the podcast host is killing people by spreading COVID misinformation. While claiming that they are in favour of free speech, the talking heads on CBS Mornings declared Rogans show to be dangerous. You have a First Amendment right to say what you want. You dont have a First Amendment right to appear on a platform as large as Spotify, thats the issue, said one of the script readers. After flashing up a graph showing rates of unvaccinated hospitalisations (figures grossly distorted by the lack of distinction between people admitted WITH and DUE to COVID) the gaggle agreed that the virus is a life and death issue, urging that Rogan should be silenced. One of the bunch argued that you cant just turn off Rogans show because too many people wont do that, they will continue to listen, suggesting that the only course of action is to completely silence Rogan.

An emergency use authorization request is expected to be made to the US Food and Drug Administration (FDA) as early as February 1, 2022.

Pfizer has announced it is planning to ask the FDA to authorize its COVID-19 vaccine for young children.

Pfizer Inc and Germany''s BioNTech SE are expected to submit an emergency use authorisation request as early as Tuesday to the US Food and Drug Administration (FDA) for vaccines for children aged six months to 5 years, the Washington Post reported.

Regulators urging drugmaker to apply for emergency authorization of 2-dose regimen of shot for kids aged 6 months to 5 years old while awaiting data on 3-dose course

Pfizer and Germany''s BioNTech are expected to submit an emergency use authorization request on Tuesday to the U.S. Food and Drug Administration for vaccines for children aged six months to 5 years, the Washington Post reported on Monday.